Select Medical (SEM) Set to Announce Quarterly Earnings on Thursday

Select Medical (NYSE:SEM) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Select Medical to post earnings of $0.55 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Select Medical (NYSE:SEM) last announced its earnings results on Friday, February 23rd. The health services provider reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. Select Medical had a net margin of 3.65% and a return on equity of 16.93%. The company’s revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.22 earnings per share. On average, analysts expect Select Medical to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Select Medical Stock Performance

Shares of Select Medical stock opened at $27.97 on Tuesday. The company has a debt-to-equity ratio of 2.32, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a 50 day simple moving average of $28.26 and a 200 day simple moving average of $25.80. Select Medical has a fifty-two week low of $21.28 and a fifty-two week high of $33.51. The firm has a market cap of $3.59 billion, a P/E ratio of 14.64, a P/E/G ratio of 1.08 and a beta of 1.37.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 13th. Stockholders of record on Friday, March 1st were paid a $0.125 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.50 annualized dividend and a dividend yield of 1.79%. Select Medical’s dividend payout ratio (DPR) is currently 26.18%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on SEM. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a report on Friday, March 22nd. Benchmark reiterated a “buy” rating and set a $39.00 price target on shares of Select Medical in a research report on Friday, April 12th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $34.40.

Insider Buying and Selling at Select Medical

In other news, Chairman Robert A. Ortenzio sold 50,000 shares of the company’s stock in a transaction dated Monday, April 8th. The stock was sold at an average price of $29.90, for a total value of $1,495,000.00. Following the completion of the sale, the chairman now directly owns 6,689,668 shares of the company’s stock, valued at approximately $200,021,073.20. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 17.50% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.